A new study, not affiliated with Cleveland Clinic, finds that Cleveland Clinic Lerner College of Medicine produced the highest percentage of medical students who elected to enter urology and match into the field over a five-year-period (2016-2021). Residency Program Director Steven Campbell, MD, PhD, comments.
Chronic Urticaria: Improved Understanding, Improved Treatments
A new research paper describes a stepped-care treatment to help improve the quality of life for patients with chronic uticaria.
ASCO Releases New Guidelines for Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers
New guidelines support oncologists in treating recurrent and metastatic head and neck cancers
Diagnosis and Treatment of Refractory Pelvic Pain
Surgical techniques: Doctors who are confident in their laparoscopic skills and pelvic anatomy, and who follow the right steps, can perform laparoscopic resection of an adenomyoma.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Case Study: TNF Inhibitor Plays Role in Unraveling a Challenging Diagnosis
A patient with a long history of inflammation in his right hand seemed an unlikely candidate for the infection that was finally diagnosed.
Case Study: Main Duct Intraductal Papillary Mucinous Neoplasm Treated with Total Pancreatectomy and Chemotherapy
Total pancreatectomy and splenectomy needed to address pancreatic cancer risk
Study Pinpoints US Geographic Hot Spots for Delayed Kidney Transplant Waitlisting Practices
Cleveland Clinic study authors say findings are first step in pinpointing areas where waitlist access for kidney transplant could be improved.
Optimal Management of High Risk Immunocompromised Patients in the COVID-19 Era
Rheumatologists are called upon to know which patients are more vulnerable to COVID-19, to counsel on risk, and to recommend vaccination and PrEP when appropriate.
Does Peripheral Inflammation Drive Alzheimer’s Disease Progression?
New NIH-funded research combines analysis of blood-brain barrier changes with detailed characterization of AD-associated immunity changes. The aim is insights that lead to new avenues of therapy.
Real World Experience with Tixagevimab/Cilgavimab in B-Cell-Depleted Patients
Early results were positive in a study of the preventive treatment of COVID-19 with xagevimab/cilgavimab for patients who were unlikely to respond sufficiently or at all to vaccination.